Qizhi Tang

Sep 3, 2024 | nature.com | Alessandro Grattoni |Andres Garcia |Andrés García |Andrew R. Pepper |Michael A Brehm |Klearchos K. Papas | +9 more

AbstractType 1 diabetes mellitus (T1DM) is a growing global health concern that affects approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune destruction of pancreatic β cells, leading to a disruption in glucose homeostasis. Therapeutic intervention for T1DM requires a complex regimen of glycaemic monitoring and the administration of exogenous insulin to regulate blood glucose levels.

May 16, 2024 | nature.com | Qizhi Tang

AbstractTreatment options for T3N1 stage gastric cancer exhibit regional variation, with optimal approach remaining unclear. We derived our data from the SEER database, using Cox proportional risk regression models for univariate and multivariate analyses of 5-years overall survival (5yOS) and 5-years cancer-specific survival (5yCSS).

Sep 25, 2023 | frontiersin.org | Giang Tran |Qizhi Tang

IntroductionThe TR1 cell subset has been implicated in the maintenance of peripheral tolerance against immune-mediated pathologies. TR1-like cells were first documented in severe combined immunodeficiency (SCID) patients that did not develop graft-versus-host disease (GvHD) after receiving HLA-mismatched fetal liver hematopoietic stem cell transplants (1). Subsequent work by Groux et al.

Aug 29, 2023 | nature.com | Qizhi Tang

AbstractThe definitive treatment for end-stage renal disease is kidney transplantation, which remains limited by organ availability and post-transplant complications. Alternatively, an implantable bioartificial kidney could address both problems while enhancing the quality and length of patient life.

Jul 12, 2023 | nature.com | Qizhi Tang

NEWS AND VIEWS 12 July 2023 Inflammation caused by surgical trauma limits the survival of transplanted stem-cell-derived neurons in rodent models of Parkinson’s disease. Co-transplanting immune cells called regulatory T cells improves the therapy’s efficacy.